Business Context and Reporting Period
This Form 8-K is filed by NanoVibronix, Inc. (trading symbol: NAOV) on October 8, 2024. The filing addresses a critical corporate governance event regarding the company's listing status on the Nasdaq Capital Market. Note: The request metadata references "Envue Medical, Inc.," but the source text explicitly identifies the registrant as NanoVibronix, Inc.
Key Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on regulatory compliance regarding stock listing standards.
Material Changes
- Delisting Notice: On October 8, 2024, the Nasdaq Listing Qualifications Department notified the Company that its securities are subject to delisting.
- Non-Compliance: The Company failed to regain compliance with Nasdaq Listing Rule 5550(a)(2) by the October 7, 2024 deadline. This rule requires a minimum bid price of $1.00 per share for 30 consecutive business days.
- Historical Context: The Company originally received a non-compliance letter on April 10, 2024, and was granted a 180-calendar day compliance period which has now expired.
Outlook, Risks, and Management Commentary
- Management Action: The Company plans to timely request a hearing before the Nasdaq Hearings Panel. This request will stay any further delisting action pending the hearing's completion and any potential extensions.
- Strategic Options: Management is considering all available options to regain compliance with the minimum bid price rule.
- Risks and Contingencies: There is no assurance that the Hearings Panel will grant the request for continued listing or that the Company will be able to demonstrate compliance within any granted extension period. Failure to maintain listing could result in the stock being delisted from Nasdaq.
Investor Verification Checklist
- Verify the current trading status of NAOV on the Nasdaq Capital Market.
- Confirm the filing date and status of the Company's request for a hearing before the Nasdaq Hearings Panel.
- Monitor the Company's stock price to assess if it has reached the $1.00 minimum bid price threshold.
- Review subsequent filings for the outcome of the hearing or any announcements regarding a reverse stock split or other capital structure changes intended to regain compliance.